egfr mutations in advanced nsclc - targeted therapies in lung cancer 2023
Published 1 year ago • 465 plays • Length 4:10Download video MP4
Download video MP3
Similar videos
-
6:26
metastatic egfr nsclc: recent developments - targeted therapies in lung cancer 2023
-
3:02
resistance mechanisms in egfr nsclc treatment - targeted therapies in lung cancer 2023
-
3:14
advancements of targeted therapy for egfr mutations in nsclc
-
4:02
treatment of egfr mutated nsclc - 2022 program: targeted therapies forum - english
-
4:40
ntrk nsclc: treatment options and side effects - targeted therapies in lung cancer 2023
-
2:43
post-osimertinib treatment options for egfr nsclc - targeted therapies in lung cancer 2023
-
2:44
combination therapy with osimertinib for egfr nsclc - targeted therapies in lung cancer 2023
-
3:02
the future of ret nsclc treatment - targeted therapies in lung cancer 2023
-
6:06
the adaura trial: the effect on egfr treatment - targeted therapies in lung cancer 2023
-
4:22
what is egfr in lung cancer? - 2022 program: targeted therapies forum
-
3:20
egfr mutated nsclc disease progression on osimertinib - 2022 program: targeted therapies forum
-
0:31
biomarkers in nsclc - targeted therapies in lung cancer 2023 - #youtubeshorts #shorts
-
1:46
immunotherapy for patients with resectable nsclc & driver mutation-targeted therapies in lung cancer
-
4:02
egfr resisters: an advocacy group - targeted therapies in lung cancer 2023
-
7:37
rare fusions in nsclc: ret - targeted therapies in lung cancer 2023
-
2:30
acquired resistance to osimertinib in egfr nsclc - 2022 program: targeted therapies forum - english
-
22:49
grace targeted therapies lung cancer 2021 - management of uncommon egfr mutations including exon 20
-
4:09
egfr mutations: uncommon treatment & insurance complications -2022 program: targeted therapies forum
-
2:49
q&a: are there ongoing trials for rare nsclc mutations? - targeted therapies in lung cancer 2023